SSY Group Ltd. is an investment holding company, which engages in the research, development, and manufacture of pharmaceutical products. The company employs 6,100 full-time employees The company went IPO on 2005-12-20. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Follow-Up Questions
Who is the CEO of SSY Group Ltd?
Mr. Jiguang Qu is the Executive Chairman of the Board of SSY Group Ltd, joining the firm since 2005.
What is the price performance of LJUIF stock?
The current price of LJUIF is $0.4025, it has decreased 0% in the last trading day.
What are the primary business themes or industries for SSY Group Ltd?
SSY Group Ltd belongs to Pharmaceuticals industry and the sector is Health Care
What is SSY Group Ltd market cap?
SSY Group Ltd's current market cap is $1.1B
Is SSY Group Ltd a buy, sell, or hold?
According to wall street analysts, 7 analysts have made analyst ratings for SSY Group Ltd, including 4 strong buy, 5 buy, 1 hold, 0 sell, and 4 strong sell
